RecruitingNot ApplicableNCT04636892

Evaluating Infrasonic Hemodynography

Clinical Correlation of a Novel Wearable Sensor to Detect Cardiovascular Mechanical and Electrical Properties Through Infrasonic Hemodynography

Sponsor

Scripps Health

Enrollment

25 participants

Start Date

Jan 4, 2021

Study Type

INTERVENTIONAL

Conditions

Cardiovascular Diseases Pulmonary Hypertension Coronary Artery Disease Mitral Regurgitation Heart Failure, Systolic Aortic Stenosis

Summary

This comparative diagnostic accuracy study will determine the accuracy of a noninvasive wearable infrasonic sensor to detect the mechanical, electrical, and hemodynamic function of the cardiovascular system.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is evaluating a non-invasive heart monitoring technology called Infrasonic Hemodynography (IHG), which uses sound waves to measure heart function. The goal is to see how well this device performs compared to standard heart tests and whether it can detect heart conditions without the need for invasive procedures. **You may be eligible if...** - Your heart is in a normal sinus rhythm (regular heartbeat) - Your heart's pumping function (left ventricular ejection fraction) is above 53% **You may NOT be eligible if...** - You have a history of carotid artery disease - You have moderate or severe valve disease (for Group 1) - You have a pacemaker, defibrillator, or other implanted device (including a glucose monitor or TENS unit) - You have an active abnormal heart rhythm (arrhythmia) - You have significantly reduced heart pumping function (ejection fraction below 35%), unless you are in Group 4 - You have hearing loss Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.